Acetylseco hemicholinium-3, a new choline acetyltransferase inhibitor useful in neuropharmacological studies.
D000109:Acetylcholine / Q000378:metabolism; D000123:Acetyltransferases / Q000032:analysis / Q000037:antagonists & inhibitors*; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D002247:Carbon Isotopes; D002552:Cerebral Ventricles; D002794:Choline / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006426:Hemicholinium 3 / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology*; D007267:Injections; D007700:Kinetics; D008297:Male; D051381:Rats; D013997:Time Factors
D002247:Carbon Isotopes; D006426:Hemicholinium 3; D000123:Acetyltransferases; D002794:Choline; D000109:Acetylcholine